{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:41:34Z","timestamp":1792701694498,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-024-06426-3","type":"journal-article","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T19:36:47Z","timestamp":1742931407000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["\u201cPharmacological management of acute agitation in psychiatric patients: an umbrella review\u201d"],"prefix":"10.1186","volume":"25","author":[{"given":"Erasmo Saucedo","family":"Uribe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia Alejandra Bravo","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Emanuel Navarrete","family":"Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha Medrano","family":"Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Huereca","family":"Lucio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin Eduardo Rojas","family":"Guzm\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Carlos Lozano","family":"Carrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"key":"6426_CR1","doi-asserted-by":"crossref","unstructured":"Pacciardi B, Mauri M, Cargioli C, Belli S, Cotugno B, Di Paolo L, et al. Issues in the management of acute agitation: how much current guidelines consider safety? Front Psychiatry. 2013;4. Available from: http:\/\/journal.frontiersin.org\/article\/10.3389\/fpsyt.2013.00026\/abstract. Cited 2023 Nov 15.","DOI":"10.3389\/fpsyt.2013.00026"},{"issue":"S17","key":"6426_CR2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1017\/S1092852900026286","volume":"12","author":"K Nordstrom","year":"2007","unstructured":"Nordstrom K, Allen MH. Managing the acutely agitated and psychotic patient. CNS Spectr. 2007;12(S17):5\u201311.","journal-title":"CNS Spectr"},{"issue":"3","key":"6426_CR3","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1192\/bjp.180.3.278","volume":"180","author":"M Soyka","year":"2002","unstructured":"Soyka M. Aggression in schizophrenia: assessment and prevalence. Br J Psychiatry. 2002;180(3):278\u20139.","journal-title":"Br J Psychiatry"},{"issue":"1","key":"6426_CR4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.genhosppsych.2003.08.002","volume":"26","author":"MH Allen","year":"2004","unstructured":"Allen MH, Currier GW. Use of restraints and pharmacotherapy in academic psychiatric emergency services. Gen Hosp Psychiatry. 2004;26(1):42\u20139.","journal-title":"Gen Hosp Psychiatry"},{"issue":"3","key":"6426_CR5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1023\/B:PSAQ.0000031791.53142.85","volume":"75","author":"L Citrome","year":"2004","unstructured":"Citrome L. New treatments for agitation. Psychiatr Q. 2004;75(3):197\u2013213.","journal-title":"Psychiatr Q"},{"key":"6426_CR6","doi-asserted-by":"publisher","unstructured":"SP A, A U, K S. Needs and problems of the caregivers of psychiatric patients with violent behaviors. Cureus. 2024. https:\/\/doi.org\/10.7759\/cureus.57228.","DOI":"10.7759\/cureus.57228"},{"key":"6426_CR7","doi-asserted-by":"crossref","unstructured":"Overall JE, Gorham DR. The brief psychiatric rating scale. Psychol Rep. 1962; Available from: https:\/\/journals.sagepub.com\/doi\/abs\/10.2466\/pr0.1962.10.3.799.","DOI":"10.1037\/t01554-000"},{"issue":"2","key":"6426_CR8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261\u201376.","journal-title":"Schizophr Bull"},{"issue":"4","key":"6426_CR9","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1176\/jnp.9.4.541","volume":"9","author":"S Yudofsky","year":"1997","unstructured":"Yudofsky S. The Overt Agitation Severity Scale for the objective rating of agitation. J Neuropsychiatry Clin Neurosci. 1997;9(4):541\u20138.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"2","key":"6426_CR10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.5811\/westjem.2015.12.28763","volume":"17","author":"S Zeller","year":"2016","unstructured":"Zeller S, Citrome L. Managing agitation associated with schizophrenia and bipolar disorder in the emergency setting. West J Emerg Med. 2016;17(2):165\u201372.","journal-title":"West J Emerg Med"},{"key":"6426_CR11","doi-asserted-by":"crossref","unstructured":"Ahmed U, Jones H, Adams CE. Chlorpromazine for psychosis induced aggression or agitation. Cochrane Database Syst Rev. 2010;(4). Available from: https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD007445.pub2\/abstract. Cited 2023 Nov 28.","DOI":"10.1002\/14651858.CD007445.pub2"},{"issue":"11","key":"6426_CR12","first-page":"CD009377","volume":"14","author":"MJ Powney","year":"2012","unstructured":"Powney MJ, Adams CE, Jones H. Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation). Cochrane Database Syst Rev. 2012;14(11):CD009377.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"6426_CR13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2165\/00023210-200519020-00005","volume":"19","author":"AJ Wagstaff","year":"2005","unstructured":"Wagstaff AJ, Easton J, Scott LJ. Intramuscular olanzapine. CNS Drugs. 2005;19(2):147\u201364.","journal-title":"CNS Drugs"},{"issue":"100","key":"6426_CR14","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.jad.2007.02.005","volume":"1","author":"PF Buckley","year":"2007","unstructured":"Buckley PF, Paulsson B, Brecher M. Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine. J Affect Disord. 2007;1(100):S33-43.","journal-title":"J Affect Disord"},{"key":"6426_CR15","doi-asserted-by":"crossref","unstructured":"De Deyn PP. Risperidone in the management of agitation and aggression associated with psychiatric disorders. Eur Psychiatry - Camb Core. 2006;21. Available from: https:\/\/www.cambridge.org\/core\/journals\/european-psychiatry\/article\/abs\/risperidone-in-the-management-of-agitation-and-aggression-associated-with-psychiatric-disorders\/DD9BD9761CA62757DE5EA7E7422DA22A. Cited 2023 Nov 28.","DOI":"10.1016\/j.eurpsy.2005.11.003"},{"issue":"4","key":"6426_CR16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-0043-100766","volume":"50","author":"SJ Kousgaard","year":"2017","unstructured":"Kousgaard SJ, Licht RW, Nielsen RE. Effects of intramuscular midazolam and lorazepam on acute agitation in non-elderly subjects - A systematic review. Pharmacopsychiatry. 2017;50(4):129\u201335.","journal-title":"Pharmacopsychiatry"},{"issue":"4","key":"6426_CR17","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0736-4679(98)00045-6","volume":"16","author":"J Richards","year":"1998","unstructured":"Richards J, Derlet R, Duncan D. Chemical restraint for the agitated patient in the emergency department: lorazepam versus droperidol. J Emerg Med. 1998;16(4):567\u201373.","journal-title":"J Emerg Med"},{"issue":"1","key":"6426_CR18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.genhosppsych.2006.10.012","volume":"29","author":"C Damsa","year":"2007","unstructured":"Damsa C, Adam E, De Gregorio F, Cailhol L, Lejeune J, Lazignac C, et al. Intramuscular olanzapine in patients with borderline personality disorder: an observational study in an emergency room. Gen Hosp Psychiatry. 2007;29(1):51\u20133.","journal-title":"Gen Hosp Psychiatry"},{"issue":"3","key":"6426_CR19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1055\/s-2006-941489","volume":"39","author":"JC Pascual","year":"2006","unstructured":"Pascual JC, Madre M, Soler J, Barrachina J, Campins MJ, Alvarez E, et al. Injectable atypical antipsychotics for agitation in borderline personality disorder. Pharmacopsychiatry. 2006;39(3):117\u20138.","journal-title":"Pharmacopsychiatry"},{"issue":"6","key":"6426_CR20","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/JCP.0000000000000402","volume":"35","author":"KG Kahl","year":"2015","unstructured":"Kahl KG, Negt P, Wollmer A, Jung S, Kruger THC. Inhaled loxapine for acute treatment of agitation in patients with borderline personality disorder: a case series. J Clin Psychopharmacol. 2015;35(6):741\u20133.","journal-title":"J Clin Psychopharmacol"},{"issue":"5","key":"6426_CR21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/JCP.0b013e3181b2b9f3","volume":"29","author":"EFH Saunders","year":"2009","unstructured":"Saunders EFH, Silk KR. Personality trait dimensions and the pharmacological treatment of borderline personality disorder. J Clin Psychopharmacol. 2009;29(5):461\u20137.","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"6426_CR22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11920-010-0168-9","volume":"13","author":"L Feurino","year":"2011","unstructured":"Feurino L, Silk KR. State of the art in the pharmacologic treatment of borderline personality disorder. Curr Psychiatry Rep. 2011;13(1):69\u201375.","journal-title":"Curr Psychiatry Rep"},{"key":"6426_CR23","unstructured":"Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions, Chapter 8: Assessing risk of bias in a randomized trial. Available from: https:\/\/training.cochrane.org\/handbook\/current\/chapter-08."},{"key":"6426_CR24","doi-asserted-by":"crossref","unstructured":"Shamseer L. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: Elaboration and explanation | The BMJ. 2015. Available from: https:\/\/www.bmj.com\/content\/349\/bmj.g7647. Cited 2023 Nov 26.","DOI":"10.1136\/bmj.g7647"},{"issue":"6","key":"6426_CR25","first-page":"554","volume":"21","author":"P Bosanac","year":"2013","unstructured":"Bosanac P, Hollander Y, Castle D. The comparative efficacy of intramuscular antipsychotics for the management of acute agitation. Australas Psychiatry Bull R Aust N Z Coll Psychiatr. 2013;21(6):554\u201362.","journal-title":"Australas Psychiatry Bull R Aust N Z Coll Psychiatr"},{"key":"6426_CR26","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.eurpsy.2019.01.014","volume":"57","author":"M Bak","year":"2019","unstructured":"Bak M, Weltens I, Bervoets C, De Fruyt J, Samochowiec J, Fiorillo A, et al. The pharmacological management of agitated and aggressive behaviour: A systematic review and meta-analysis. Eur Psychiatry J Assoc Eur Psychiatr. 2019;57:78\u2013100.","journal-title":"Eur Psychiatry J Assoc Eur Psychiatr"},{"issue":"2","key":"6426_CR27","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.auec.2020.08.004","volume":"24","author":"E Muir-Cochrane","year":"2021","unstructured":"Muir-Cochrane E, Grimmer K, Gerace A, Bastiampillai T, Oster C. Safety and effectiveness of olanzapine and droperidol for chemical restraint for non-consenting adults: a systematic review and meta-analysis. Australas Emerg Care. 2021;24(2):96\u2013111.","journal-title":"Australas Emerg Care"},{"issue":"3","key":"6426_CR28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.clinthera.2010.03.006","volume":"32","author":"SL Zeller","year":"2010","unstructured":"Zeller SL, Rhoades RW. Systematic reviews of assessment measures and pharmacologic treatments for agitation. Clin Ther. 2010;32(3):403\u201325.","journal-title":"Clin Ther"},{"issue":"2","key":"6426_CR29","doi-asserted-by":"crossref","first-page":"e000016","DOI":"10.1136\/gpsych-2018-000016","volume":"31","author":"L Su","year":"2018","unstructured":"Su L, Lu Z, Shi S, Xu Y. Ziprasidone, haloperidol and clonazepam intramuscular administration in the treatment of agitation symptoms in Chinese patients with schizophrenia: a network meta-analysis. Gen Psychiatry. 2018;31(2):e000016.","journal-title":"Gen Psychiatry"},{"key":"6426_CR30","doi-asserted-by":"crossref","first-page":"628965","DOI":"10.3389\/fpsyt.2021.628965","volume":"12","author":"M Amore","year":"2021","unstructured":"Amore M, D\u2019Andrea M, Fagiolini A. Treatment of agitation with lorazepam in clinical practice: a systematic review. Front Psychiatry. 2021;12:628965.","journal-title":"Front Psychiatry"},{"issue":"4","key":"6426_CR31","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/hup.2535","volume":"31","author":"Y Dundar","year":"2016","unstructured":"Dundar Y, Greenhalgh J, Richardson M, Dwan K. Pharmacological treatment of acute agitation associated with psychotic and bipolar disorder: a systematic review and meta-analysis. Hum Psychopharmacol. 2016;31(4):268\u201385.","journal-title":"Hum Psychopharmacol"},{"key":"6426_CR32","doi-asserted-by":"publisher","unstructured":"Huf G, Alexander J, Gandhi P, Allen MH. Haloperidol plus promethazine for psychosis-induced aggression. Cochrane Database Syst Rev. 2016;11(11). https:\/\/doi.org\/10.1002\/14651858.CD005146.pub3.","DOI":"10.1002\/14651858.CD005146.pub3"},{"issue":"12","key":"6426_CR33","first-page":"CD003079","volume":"12","author":"H Zaman","year":"2017","unstructured":"Zaman H, Sampson SJ, Beck AL, Sharma T, Clay FJ, Spyridi S, et al. Benzodiazepines for psychosis-induced aggression or agitation. Cochrane Database Syst Rev. 2017;12(12):CD003079.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"6426_CR34","first-page":"CD008074","volume":"1","author":"EG Ostinelli","year":"2018","unstructured":"Ostinelli EG, Jajawi S, Spyridi S, Sayal K, Jayaram MB. Aripiprazole (intramuscular) for psychosis-induced aggression or agitation (rapid tranquillisation). Cochrane Database Syst Rev. 2018;1(1):CD008074.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"6426_CR35","first-page":"CD009412","volume":"4","author":"EG Ostinelli","year":"2018","unstructured":"Ostinelli EG, Hussein M, Ahmed U, Rehman FU, Miramontes K, Adams CE. Risperidone for psychosis-induced aggression or agitation (rapid tranquillisation). Cochrane Database Syst Rev. 2018;4(4):CD009412.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"6426_CR36","first-page":"CD003729","volume":"18","author":"RB Belgamwar","year":"2005","unstructured":"Belgamwar RB, Fenton M. Olanzapine IM or velotab for acutely disturbed\/agitated people with suspected serious mental illnesses. Cochrane Database Syst Rev. 2005;18(2):CD003729.","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"6426_CR37","first-page":"CD002830","volume":"12","author":"MA Khokhar","year":"2016","unstructured":"Khokhar MA, Rathbone J. Droperidol for psychosis-induced aggression or agitation. Cochrane Database Syst Rev. 2016;12(12):CD002830.","journal-title":"Cochrane Database Syst Rev"},{"key":"6426_CR38","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1111\/pan.12669","volume":"25","author":"SL van Hoff","year":"2015","unstructured":"van Hoff SL, O\u2019Neill ES, Cohen LC, Collins BA. Does a prophylactic dose of propofol reduce emergence agitation in children receiving anesthesia? A systematic review and meta-analysis. Paediatr Anaesth. 2015;25:668\u201376. https:\/\/doi.org\/10.1111\/pan.12669.","journal-title":"Paediatr Anaesth"},{"issue":"2","key":"6426_CR39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2344\/0003-3006-60.3.67","volume":"60","author":"Z Messieha","year":"2013","unstructured":"Messieha Z. Prevention of sevoflurane delirium and agitation with propofol. Anesth Prog. 2013;60(2):67\u201371. https:\/\/doi.org\/10.2344\/0003-3006-60.3.67.","journal-title":"Anesth Prog"},{"key":"6426_CR40","doi-asserted-by":"crossref","unstructured":"Gillies D, Sampson S, Beck A, Rathbone J. Benzodiazepines for psychosis-induced aggression or agitation. Cochrane Database Syst Rev. 2013;(4). Available from: https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD003079.pub3\/abstract. Cited 2023 Nov 18.","DOI":"10.1002\/14651858.CD003079.pub3"},{"issue":"7","key":"6426_CR41","first-page":"CD009377","volume":"7","author":"EG Ostinelli","year":"2017","unstructured":"Ostinelli EG, Brooke-Powney MJ, Li X, Adams CE. Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation). Cochrane Database Syst Rev. 2017;7(7):CD009377.","journal-title":"Cochrane Database Syst Rev."},{"issue":"3","key":"6426_CR42","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jemermed.2017.10.011","volume":"54","author":"LS Zun","year":"2018","unstructured":"Zun LS. Evidence-based review of pharmacotherapy for acute agitation. part 1: Onset of efficacy. J Emerg Med. 2018;54(3):364\u201374.","journal-title":"J Emerg Med."},{"issue":"2","key":"6426_CR43","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/jcpt.12785","volume":"44","author":"F Bloch","year":"2019","unstructured":"Bloch F, Karoui I, Boutalha S, Defouilloy C, Dubaele JM. Tolerability of midazolam to treat acute agitation in elderly demented patients: A systematic review. J Clin Pharm Ther. 2019;44(2):143\u20137.","journal-title":"J Clin Pharm Ther"},{"key":"6426_CR44","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jpsychires.2015.07.005","volume":"68","author":"T Kishi","year":"2015","unstructured":"Kishi T, Matsunaga S, Iwata N. Intramuscular olanzapine for agitated patients: a systematic review and meta-analysis of randomized controlled trials. J Psychiatr Res. 2015;68:198\u2013209.","journal-title":"J Psychiatr Res"},{"key":"6426_CR45","doi-asserted-by":"crossref","unstructured":"Marder SR. A review of agitation in mental illness: treatment guidelines and current therapies. J Clin Psychiatry. 2006;67 Suppl 10:13\u201321.","DOI":"10.4088\/JCP.0706e03"},{"issue":"1","key":"6426_CR46","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12991-015-0053-3","volume":"14","author":"D Popovic","year":"2015","unstructured":"Popovic D, Nuss P, Vieta E. Revisiting loxapine: a systematic review. Ann Gen Psychiatry. 2015;14(1):15.","journal-title":"Ann Gen Psychiatry"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-024-06426-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-024-06426-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-024-06426-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T19:37:48Z","timestamp":1742931468000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-024-06426-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6426"],"URL":"https:\/\/doi.org\/10.1186\/s12888-024-06426-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3851345\/v1","asserted-by":"object"}]},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]},"assertion":[{"value":"10 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors consent for publication in order of the policies of BMC Psychiatry.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"273"}}